Abstract |
NK cells hold promise for protecting hosts from cancer and pathogen infection through direct killing and expressing immune-regulatory cytokines. In our study, a genetically modified K562 cell line with surface expression of 4-1BBL and MICA was constructed to expand functional NK cells in vitro for further adoptive immunotherapy against cancer. After a long-term up to 21 day co-culture with newly isolated peripheral blood mononuclear cells (PBMCs) in the presence of soluble IL-21 (sIL-21), notable increase in proportion of expanded NK cells was observed, especially the CD56(bright)CD16(+) subset. Apparent up-regulation of activating receptors CD38, CD69 and NKG2D was detected on expanded NK cells, so did inhibitory receptor CD94; the cytotoxicity of expanded NK cells against target tumor cells exceeded that of NK cells within fresh PBMCs. The intracellular staining showed expanded NK cells produced immune-regulatory IFN-γ. Taken together, we expanded NK cells with significant up-regulation of activating NKG2D and moderate enhancement of cytotoxicity, with IFN-γ producing ability and a more heterogeneous population of NK cells. These findings provide a novel perspective on expanding NK cells in vitro for further biology study and adoptive immunotherapy of NK cells against cancer.
|
Authors | Bo Jiang, Xuan Wu, Xi-Ning Li, Xi Yang, Yulai Zhou, Haowei Yan, An-Hui Wei, Weiqun Yan |
Journal | Cellular immunology
(Cell Immunol)
Vol. 290
Issue 1
Pg. 10-20
(Jul 2014)
ISSN: 1090-2163 [Electronic] Netherlands |
PMID | 24859012
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier Inc. All rights reserved. |
Chemical References |
- 4-1BB Ligand
- Antigens, CD
- Antigens, Differentiation, T-Lymphocyte
- CD56 Antigen
- CD69 antigen
- FCGR3B protein, human
- GPI-Linked Proteins
- Histocompatibility Antigens Class I
- Interleukins
- KLRD1 protein, human
- KLRK1 protein, human
- Lectins, C-Type
- MHC class I-related chain A
- Membrane Glycoproteins
- NCAM1 protein, human
- NK Cell Lectin-Like Receptor Subfamily D
- NK Cell Lectin-Like Receptor Subfamily K
- Receptors, IgG
- Interferon-gamma
- CD38 protein, human
- ADP-ribosyl Cyclase 1
- interleukin-21
|
Topics |
- 4-1BB Ligand
(biosynthesis, genetics)
- ADP-ribosyl Cyclase 1
(biosynthesis)
- Antigens, CD
(biosynthesis)
- Antigens, Differentiation, T-Lymphocyte
(biosynthesis)
- CD56 Antigen
(biosynthesis)
- Cell Line, Tumor
- Coculture Techniques
- GPI-Linked Proteins
(biosynthesis)
- HeLa Cells
- Hep G2 Cells
- Histocompatibility Antigens Class I
(biosynthesis, genetics)
- Humans
- Immunotherapy, Adoptive
- Interferon-gamma
(biosynthesis, immunology)
- Interleukins
(biosynthesis, genetics, pharmacology)
- Killer Cells, Natural
(immunology)
- Lectins, C-Type
(biosynthesis)
- Lymphocyte Activation
(immunology)
- Membrane Glycoproteins
(biosynthesis)
- NK Cell Lectin-Like Receptor Subfamily D
(biosynthesis)
- NK Cell Lectin-Like Receptor Subfamily K
(biosynthesis)
- Neoplasms
(immunology, therapy)
- Receptors, IgG
(biosynthesis)
|